Confidence Intervals for Seroprevalence
暂无分享,去创建一个
[1] Thomas J. DiCiccio,et al. ON BOOTSTRAP PROCEDURES FOR SECOND-ORDER ACCURATE CONFIDENCE LIMITS IN PARAMETRIC MODELS , 1999 .
[2] Peter Hall,et al. Improving the normal approximation when constructing one-sided confidence intervals for binomial or Poisson parameters , 1982 .
[3] L. Brown,et al. Interval Estimation for a Binomial Proportion , 2001 .
[4] R. Mukerjee,et al. Probability Matching Priors: Higher Order Asymptotics , 2004 .
[5] A. Gelman,et al. Bayesian Analysis of Tests with Unknown Specificity and Sensitivity , 2020, medRxiv.
[6] A. Robinson. Applied Asymptotics: Case Studies in Small-sample Statistics , 2008 .
[7] Teppei Yamamoto. Understanding the Past: Statistical Analysis of Causal Attribution , 2012 .
[8] Thomas A. Severini,et al. On the relationship between Bayesian and non-Bayesian elimination of nuisance parameters , 1999 .
[9] Stephen E. Fienberg,et al. Testing Statistical Hypotheses , 2005 .
[10] John P. A. Ioannidis,et al. Exact inference for disease prevalence based on a test with unknown specificity and sensitivity , 2020, Journal of applied statistics.
[11] S. Mallapaty. Antibody tests suggest that coronavirus infections vastly exceed official counts , 2020, Nature.
[12] S. Walter,et al. Estimating the error rates of diagnostic tests. , 1980, Biometrics.
[13] G. Alastair Young,et al. Parametric bootstrapping with nuisance parameters , 2005 .
[14] G. Alter,et al. The Power of Antibody-Based Surveillance , 2020, The New England journal of medicine.
[15] Peter Ganong,et al. Why Do Borrowers Default on Mortgages? A New Method for Causal Attribution , 2020, SSRN Electronic Journal.
[16] S D Walter,et al. Estimation of test error rates, disease prevalence and relative risk from misclassified data: a review. , 1988, Journal of clinical epidemiology.
[17] Alan Agresti,et al. Unconditional small-sample confidence intervals for the odds ratio. , 2002, Biostatistics.
[18] J. Ioannidis,et al. COVID-19 antibody seroprevalence in Santa Clara County, California , 2020, medRxiv.
[19] J. L. Jensen. The modified signed likelihood statistic and saddlepoint approximations , 1992 .
[20] R. Redfield,et al. Covid-19 — Navigating the Uncharted , 2020, The New England journal of medicine.
[21] Mervyn J. Silvapulle,et al. A Test in the Presence of Nuisance Parameters , 1996 .
[22] N. Reid,et al. On conditional inference for a real parameter: A differential approach on the sample space , 1988 .
[23] Anthony C. Davison,et al. Applied Asymptotics: Case Studies in Small-Sample Statistics , 2007 .
[24] Thomas J. DiCiccio,et al. Simple and accurate one‐sided inference from signed roots of likelihood ratios , 2001 .
[25] Florian Krammer,et al. Serology assays to manage COVID-19 , 2020, Science.
[26] Azeem M. Shaikh,et al. Consonance and the closure method in multiple testing , 2009 .
[27] P. Glasziou,et al. Estimating the seroprevalence of SARS-CoV-2 infections: systematic review , 2020, medRxiv.
[28] B. Efron. Nonparametric standard errors and confidence intervals , 1981 .
[29] B. Gladen,et al. Estimating prevalence from the results of a screening test. , 1978, American journal of epidemiology.
[30] B. Efron. Bootstrap confidence intervals for a class of parametric problems , 1985 .
[31] Petter Laake,et al. Recommended confidence intervals for two independent binomial proportions , 2015, Statistical methods in medical research.
[32] Z. Anusz. [Statistics in epidemiology]. , 1974, Pielegniarka i polozna.
[33] Jens Ledet Jensen,et al. Is the 'improved likelihood ratio statistic' really improved in the discrete case? , 1989 .
[34] B. Efron. Better Bootstrap Confidence Intervals , 1987 .
[35] G. Rodger,et al. Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison , 2020, The Lancet Infectious Diseases.
[36] E. Mammen. The Bootstrap and Edgeworth Expansion , 1997 .
[37] R. Berger,et al. P Values Maximized Over a Confidence Set for the Nuisance Parameter , 1994 .
[38] S. T. Bennett,et al. Estimating COVID-19 Antibody Seroprevalence in Santa Clara County, California. A re-analysis of Bendavid et al. , 2020, medRxiv.
[39] E. S. Pearson,et al. THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL , 1934 .
[40] James R. Carpenter,et al. Test inversion bootstrap confidence intervals , 1999 .
[41] Devy M. Emperador,et al. Antibody tests for identification of current and past infection with SARS‐CoV‐2 , 2020, The Cochrane database of systematic reviews.
[42] O. E. Barndorff-Nielsen,et al. Infereni on full or partial parameters based on the standardized signed log likelihood ratio , 1986 .
[43] Judea Pearl,et al. Probabilities Of Causation: Three Counterfactual Interpretations And Their Identification , 1999, Synthese.
[44] Panos Toulis. Estimation of Covid-19 prevalence from serology tests: A partial identification approach , 2020, Journal of Econometrics.
[45] D. Lawley. A GENERAL METHOD FOR APPROXIMATING TO THE DISTRIBUTION OF LIKELIHOOD RATIO CRITERIA , 1956 .
[46] R. Peeling,et al. Serology testing in the COVID-19 pandemic response , 2020, The Lancet Infectious Diseases.
[47] Joseph P. Romano,et al. Nonparametric confidence limits by resampling methods and least favorable families , 1990 .
[48] D. Cox,et al. Parameter Orthogonality and Approximate Conditional Inference , 1987 .
[49] Joseph P. Romano,et al. A Practical Two-Step Method for Testing Moment Inequalities , 2014 .
[50] Paul R. Rosenbaum,et al. Effects attributable to treatment: Inference in experiments and observational studies with a discrete pivot , 2001 .